Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrectomy | 3 | 2018 | 32 | 1.430 |
Why?
|
| Prostatic Neoplasms | 8 | 2018 | 114 | 1.290 |
Why?
|
| Kidney Neoplasms | 2 | 2018 | 69 | 0.730 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 43 | 0.610 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2017 | 9 | 0.590 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 89 | 0.590 |
Why?
|
| Renal Veins | 1 | 2017 | 3 | 0.580 |
Why?
|
| Renal Artery | 1 | 2017 | 6 | 0.580 |
Why?
|
| Surgical Stapling | 1 | 2017 | 7 | 0.580 |
Why?
|
| Image-Guided Biopsy | 1 | 2017 | 31 | 0.580 |
Why?
|
| Laparoscopy | 2 | 2017 | 171 | 0.570 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 39 | 0.570 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 103 | 0.530 |
Why?
|
| Postoperative Complications | 3 | 2018 | 997 | 0.530 |
Why?
|
| Prostate | 5 | 2018 | 37 | 0.510 |
Why?
|
| Ultrasonography | 1 | 2017 | 271 | 0.500 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 691 | 0.420 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 404 | 0.400 |
Why?
|
| Prostate-Specific Antigen | 3 | 2006 | 16 | 0.350 |
Why?
|
| Middle Aged | 12 | 2018 | 10239 | 0.320 |
Why?
|
| Rectum | 3 | 2018 | 66 | 0.320 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2018 | 54 | 0.300 |
Why?
|
| Adenocarcinoma | 2 | 2007 | 206 | 0.300 |
Why?
|
| Aorta, Abdominal | 1 | 2007 | 6 | 0.290 |
Why?
|
| Vena Cava, Inferior | 1 | 2007 | 13 | 0.280 |
Why?
|
| Aged | 11 | 2018 | 10079 | 0.280 |
Why?
|
| Retrospective Studies | 5 | 2018 | 3665 | 0.270 |
Why?
|
| Kidney | 1 | 2007 | 181 | 0.250 |
Why?
|
| Kidney Transplantation | 1 | 2007 | 126 | 0.250 |
Why?
|
| Incidence | 2 | 2018 | 790 | 0.250 |
Why?
|
| Pneumothorax | 1 | 2005 | 12 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 161 | 0.240 |
Why?
|
| Unnecessary Procedures | 1 | 2005 | 28 | 0.240 |
Why?
|
| Clinical Competence | 1 | 2007 | 241 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 1314 | 0.220 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 5192 | 0.220 |
Why?
|
| Genital Neoplasms, Male | 1 | 2002 | 3 | 0.210 |
Why?
|
| Seminal Vesicles | 1 | 2002 | 4 | 0.210 |
Why?
|
| Neurilemmoma | 1 | 2002 | 17 | 0.210 |
Why?
|
| Male | 11 | 2018 | 16499 | 0.200 |
Why?
|
| Humans | 13 | 2018 | 31070 | 0.190 |
Why?
|
| Adult | 6 | 2018 | 8949 | 0.180 |
Why?
|
| Fluoroquinolones | 1 | 2018 | 28 | 0.160 |
Why?
|
| False Positive Reactions | 1 | 2018 | 36 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 1935 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2017 | 3809 | 0.150 |
Why?
|
| Lung | 1 | 2018 | 173 | 0.150 |
Why?
|
| Models, Educational | 1 | 2017 | 37 | 0.150 |
Why?
|
| Urology | 1 | 2017 | 17 | 0.150 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 115 | 0.140 |
Why?
|
| Arteriovenous Fistula | 1 | 2017 | 10 | 0.140 |
Why?
|
| Ligation | 1 | 2017 | 33 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2018 | 303 | 0.140 |
Why?
|
| Simulation Training | 1 | 2017 | 43 | 0.140 |
Why?
|
| Operative Time | 1 | 2017 | 85 | 0.140 |
Why?
|
| Predictive Value of Tests | 3 | 2007 | 551 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 344 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 420 | 0.130 |
Why?
|
| Prostatectomy | 2 | 2005 | 20 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2007 | 1898 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 818 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2017 | 227 | 0.110 |
Why?
|
| Biopsy | 2 | 2018 | 249 | 0.100 |
Why?
|
| Biopsy, Needle | 3 | 2006 | 105 | 0.090 |
Why?
|
| Female | 4 | 2018 | 17018 | 0.090 |
Why?
|
| Young Adult | 1 | 2017 | 2063 | 0.090 |
Why?
|
| Comorbidity | 2 | 2018 | 508 | 0.080 |
Why?
|
| Uterine Prolapse | 1 | 2007 | 4 | 0.070 |
Why?
|
| Physical Examination | 2 | 2005 | 118 | 0.070 |
Why?
|
| Surgical Mesh | 1 | 2007 | 24 | 0.070 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2007 | 13 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2007 | 24 | 0.070 |
Why?
|
| Digital Rectal Examination | 1 | 2006 | 3 | 0.070 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 41 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 39 | 0.070 |
Why?
|
| Graft Survival | 1 | 2007 | 98 | 0.070 |
Why?
|
| Urination Disorders | 1 | 2005 | 7 | 0.060 |
Why?
|
| Auscultation | 1 | 2005 | 6 | 0.060 |
Why?
|
| Pleura | 1 | 2005 | 10 | 0.060 |
Why?
|
| Respiratory Sounds | 1 | 2005 | 10 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 30 | 0.060 |
Why?
|
| Case Management | 1 | 2005 | 14 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2005 | 43 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 75 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 818 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2007 | 718 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2007 | 306 | 0.060 |
Why?
|
| Receptors, Glutamate | 1 | 2003 | 5 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 2003 | 4 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2003 | 23 | 0.050 |
Why?
|
| Length of Stay | 1 | 2005 | 339 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2003 | 83 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 1133 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2007 | 2045 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 57 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2018 | 72 | 0.040 |
Why?
|
| Self Report | 1 | 2017 | 231 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 155 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2006 | 344 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1681 | 0.030 |
Why?
|
| Risk Factors | 1 | 2018 | 2593 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2007 | 354 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2005 | 70 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 586 | 0.010 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2003 | 3 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2003 | 13 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 34 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2003 | 88 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 874 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 924 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2003 | 190 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 873 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 4724 | 0.010 |
Why?
|